TCTR20180903005已完成未知
Cinnarizine in the prophylactic treatment of childhood migraine: a comparison with propranolol
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Years 至 14 Years（—）
- 性别
- All
入选标准
- •Children aged 6-14 years who had migraine with and without aura, defined by the International International Headache Society criteria for migraine (17), were enrolled into the study. All patients experienced one or more headaches per week for at least 6 months or had severe disabling or intolerable headache before entry into the study.
排除标准
- •children who had complicated migraine that required medications other than analgesics, past treatment with migraine prophylactic agent, persistent increasing headache,
- •comorbid conditions such as seizures, abnormal neuroimaging, history of epilepsy, and history of contraindications to cinnarizine or propranolol administration.
研究者
相似试验
进行中（未招募）
1 期
ow-dose Atropine for the prevention of nearsightedness in Danish ChildreChildhood myopiaMedDRA version: 20.0Level: LLTClassification code 10036803Term: Progressive high (degenerative) myopiaSystem Organ Class: 100000004853EUCTR2018-001286-16-DKRigshospitalet150
进行中（未招募）
不适用
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPODChildren with chronic granulomatous disease (CGD).MedDRA version: 9.1Level: LLTClassification code 10008906Term: Chronic granulomatous diseaseEUCTR2008-004518-28-NLRadboud University Nijmegen Medical Centre
已完成
2 期
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD).CGDNL-OMON32626niversitair Medisch Centrum Sint Radboud20
进行中（未招募）
不适用
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPODEUCTR2008-004518-28-GBRadboud University Nijmegen Medical Centre20
未知
3 期
Phase 3 study of cetirizine dry syrup in children suffering from cutaneous disease accompanied by pruritus.Various types of cutaneous disease accompanied by pruritusJPRN-jRCT2080220121GlaxoSmithKline K.K.60